Target: The ForceChange Community
Goal: Applaud the price of the lifesaving drug, Daraprim, being lowered thanks to public backlash after a greedy CEO raised the price by 4,000 percent.
After raising the price of the lifesaving drug Daraprim from $13.50 to $750 a tablet overnight, Turing Pharmaceutical founder Martin Shkreli now said he will lower the price and make the drug more affordable. This is thanks in part to petitions like ForceChange’s Stop Ridiculous Price Increase of Life-Saving Drug. Daraprim helps treat a potentially life-threatening parasite infection in babies and patients with compromised immune systems.
Shkreli is a hedge fund manager whose company bought the rights to the drug and hiked up the price 4,000 percent overnight, causing a huge public backlash. He claimed it was better for everyone because the company could then use the profits to come up with an improved treatment option, even though if the drug was left at the heightened price hospitals would be forced to use less effective treatment options.
This is a classic case of classism and it’s disgusting that this kind of insanity is possible in today’s society. We the people let Shkreli know that this kind of action was intolerable and would not go down quietly. Let’s applaud the efforts to condemn Shkreli which have now resulted in the price of Daraprim being lowered so the drug can continue to help people.
Dear ForceChange Community,
We were all upset when Turing Pharmaceuticals founder Martin Shkreli decided to be greedy and awful by raising the price of the lifesaving drug Daraprim from $13.50 to $750 a tablet, a 4,000 percent increase, overnight. We let him know that this was completely unacceptable and we would not stand for him essentially taking away vital healthcare from those who cannot afford insane prices like that.
Because of making your voice heard, we forced Skreli to change his inhumane behavior and lower the price of the drug back to something more affordable. Now we can applaud our efforts that have resulted in the price of Daraprim being lowered so the drug can continue to save lives.
[Your Name Here]
Photo credit: Dean Hochman